La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that the Company will provide a corporate overview at the JMP Securities Life Science Conference 2015 taking place June 23–24 in New York City.

JMP Securities Life Science Conference 2015 Presentation Details

Date:     Wednesday, June 24, 2015 Time: 9:30 a.m. Eastern Time Location: Fontainebleau Room @ The St. Regis New York Webcast:

LJPC Webcast Link

A live webcast of the presentation will also be available in the Investor Relations section of La Jolla’s website at www.ljpc.com. A replay of the presentation will be available on La Jolla’s website for 30 days following the event.

About La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The Company has several product candidates in development. LJPC-501 is La Jolla’s proprietary formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension and hepatorenal syndrome. LJPC-401 is La Jolla’s novel formulation of hepcidin for the potential treatment of conditions characterized by iron overload, such as hemochromatosis and beta thalassemia. LJPC-30Sa and LJPC-30Sb are La Jolla’s next-generation gentamicin derivatives for the potential treatment of serious bacterial infections and rare genetic disorders, such as cystic fibrosis and Duchenne muscular dystrophy. For more information on La Jolla, please visit www.ljpc.com.

La Jolla Pharmaceutical CompanyGeorge F. Tidmarsh, M.D., Ph.D.President & Chief Executive Officer858-207-4264gtidmarsh@ljpc.comandDennis M. MulroyChief Financial Officer858-433-6839dmulroy@ljpc.com

La Jolla Pharmaceutical (NASDAQ:LJPC)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more La Jolla Pharmaceutical Charts.
La Jolla Pharmaceutical (NASDAQ:LJPC)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more La Jolla Pharmaceutical Charts.